Children are most susceptible to the serious effects associated with marijuana poisoning, including decreased coordination, lethargy, sedation, difficulty concentrating, and slurred speech.53 Exposure can also include severe, life-threatening symptoms such as shortness of breath and coma.33 Unintentional exposure to marijuana among children has increased every year since 2012. probably due to legalization policies in the United States. and the popularity of edibles.53 Edibles often look exactly like their THC-free counterparts, being presented in colourful packaging that appeals to children and often mimics candy.53 Effective legislation requiring child-resistant packaging for edibles can help mitigate and prevent accidental exposure in children.54 General practitioners should discuss the safe storage of all cannabis products with their patients. who live with children.54 Under the Child Abuse Prevention and Treatment Act (CAPTA), physicians report suspected child abuse and neglect.55 The 2010 law requires states to pass laws to report infants exposed to drug use to child welfare services.55 It should be noted that cannabis and marijuana are not interchangeable terms. In this position paper, cannabis is a general term used to refer to the Cannabis sativa plant. Substances extracted from the cannabis plant include marijuana, hemp, and cannabinoids. Attitudes and perceived risks of marijuana use have changed with varying degrees of legalization in the United States. The study of marijuana use is essential to assess the public health impact of improved access to marijuana, cannabinoids and cannabis products. Many forms of chronic pain management have been studied, including cancer and chemotherapy-induced pain, fibromyalgia, neuropathic pain, rheumatoid arthritis, non-cancer pain, and musculoskeletal pain. Several studies suggest that smoked THC and nabiximole were both associated with pain reduction.5,25,26 There is little mixed evidence of cannabinoids` viability for some forms of chronic pain management.5 However, there are limitations to these studies, including varying doses of THC and CBD; non-regulated products not approved by the FDA; and conflicting evidence.
Studies evaluating cannabinoids in the treatment of spasticity due to multiple sclerosis or spinal cord injury have mixed results. The cannabinoids nabiximole, dronabinol and TCH/CBD have all been associated with decreased spasticity. Nabilone and nabiximol were the only drugs with significant static decreases.2,25 Box 6000, Dept F, Rockville, MD 20849, USA The regulation of cannabis products takes into account many public health considerations. Serious public health problems include conduct disorders, exposure of adolescents to advertising, and accidental poisoning of children. After alcohol, marijuana is the most common illicit drug associated with conduct disorders and accidents.34 Marijuana slows reaction time and decision-making and significantly increases the risk of motor vehicle accidents.50 Some states have zero-tolerance policies where there is no allowable detectable level of THC while driving. while other states have set THC limits of five nanograms per milliliter or more. or at least detectable amounts of THC.51 Cannabis use, both medical and recreational, has been widespread throughout history.